Effects of Blocking NLRP3 Inflammasome on Type II Innate Lymphoid Cell Response in Allergic Rhinitis

CONCLUSION: MCC950 inhibited ILC2 responses in AR and mice models, suggesting that blocking NLRP3 inflammasome may be a promising target for AR clinical treatment.PMID:37583131 | DOI:10.22034/iji.2023.96966.2473

Source: Iranian Journal of Immunology - August 16, 2023 Category: Allergy & Immunology Authors: Guoqing Gong Peng Huang Changliang Yang Chengcheng Huang Zhao Zhang Ruiyao Chen Tingfeng Sun Guang Yang Source Type: research